Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Earnings call · FY2025 Q3
Executive readout · one minute
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Management tone
Confident
Net tone +82 · low hedging
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
4 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
Stated verbally and extracted from the transcript.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
full year 2025
|
$20M – $25M | — |
How the reported period landed and where the business moved.
Listen and read together
The spoken word highlights as audio plays. Select any word to seek to that moment.
Hello and welcome to the SES AI third quarter 2025 earnings release and call. My name is Carla and I will be coordinating your call today. During the presentation, you can register to ask questions by pressing star follow by one on your telephone keypad. If you change your mind, please press star follow by two. I will now hand you over to the chief legal officer, Carl Pickenton. To begin, please go ahead when you're ready.
Hello, everyone, and welcome to our conference call covering our third quarter 2025 results. Joining me today are Chi Chow Hu, founder and chief executive officer, and Jing Niles, chief financial officer. We issued our shareholder letter just after 4 p.m. today, which provides a business update as well as our financial results. You'll find a press release with a link to our shareholder letter and today's conference call webcast in the investor relations section of our website at ses.ai. Before we get started, this is a reminder that the discussion today may contain forward-looking information or forward-looking statements within the meaning of applicable securities legislation. These statements are based on our predictions and expectations as of today. Such statements involve certain risks, assumptions, and uncertainties, which may cause our actual or future results and performance to be materially different from those expressed or implied in these statements. The risks and uncertainties that could cause our results to differ materially from our current expectations include, but are not limited to, those detailed in our latest earnings release and in our SEC filings. This afternoon, we will review our business as well as results for the quarter. With that, I'll pass it over to Chi Chow.
Thanks, Kyle. Thanks to everyone for joining today. We had a record third quarter with more than $7 million in revenue. That's more than 100% growth over the second quarter. Our all-in on AI strategy is working remarkably. Today, I want to highlight some of the successes we've seen with this strategy and what it means for the future. We reached a major milestone this quarter that we expect to have far-reaching consequences across the revenue machine we describe in detail during our last call. That milestone was the release of our latest version of Molecular Universe, MU 1.0. MU 1.0 is a powerful and complete end-to-end AI for science workflow that includes five features. ASK, an agentic LLN with access to what we believe is the world's largest database of battery-relevant literature. Search and formulate what we believe are the world's largest databases of battery relevant molecule and formulation level properties enabled by GPU accelerated quantum mechanics computation and machine learning accelerated property prediction and design and predict chemistry specific and chemistry agnostic machine learning models respectively that can accurately predict battery state of health and end-of-life. Due to the popularity of the enterprise tier, we also launched three sub-tiers within enterprise to provide greater value to more enterprise users. In addition to cloud-based molecular universe, we expect to launch on-premise molecular universe, providing greater data security to more enterprise users. This new on-premise capability, which we will be describing in more detail in the coming months, addresses specific security and privacy needs of the world's largest battery makers that should unlock the greater share of our addressable We are incorporating MU 1.0's ask, design, and predict into our ESS products deployed by UZ around the world to collect data for on-site model training. This unprecedented ability for safety and health prediction, combined with reduced maintenance costs, truly helps differentiate our products and attract new customers. Since we completed the acquisition of UZ Energy in mid-September, our ESS revenue has been growing and is already responsible for approximately 45% of our third quarter revenue. We're very excited about the revenue potential of deploying Molecular Universe to enhance our ESS products. MU1.0's ask, search, and formulate are also helping our users identify several new electrolyte materials that we are commercializing. These include, one, improved low-temperature rate performance of lithium-ion phosphate lithium-ion cells for ESS applications, two, improved cycle life for 12% silicon lithium-ion cells for EV applications, and three, improved cycle life for lithium metal and 100% silicon lithium-ion for drones and UAM applications, and many more. To supply these materials discovered by Molecular Universe to our customers, we entered into a joint venture agreement with Heisen New Energy Materials, a leading electrolyte manufacturer with 150,000 tons of annual capacity to contract manufacture these materials so we stay capex-like. They use the groundwork for exciting revenue growth in the coming quarters. Another revenue opportunity we expect to grow in 2026 and beyond is in drones. A dependable The total supply chain of high-energy-density pouch cells is extremely rare and critical to the development of the American drones industry. To better address this burgeoning market, we are leveraging our Cheungju South Korea cell factory, incorporating the latest materials discovered from Molecular Universe to meet customer demands. In terms of potential revenues from EV, we completed B-Sample 9 site acceptance tests this summer with one auto OEM. As a result, in 2026, we expect to start commercial supply of electrolyte materials and partner with them for cell production. Overall, it's hard for us to comprehend a more consequential period than what we have experienced over the past two quarters, particularly as it relates to delivering on the goals we outlined coming into this year. For instance, we know that we wanted to break into the ESS market in a big way. Now we've done so with the acquisition of UZ Energy, and the acquisition has already delivered significant revenue in 2025. We launched three versions of Molecular Universe this year. The discoveries made by us and our customers so far have accelerated our push into materials to supply them through the Hyzen JB. We'll have more to share on our fourth quarter call about how we expect 2026 to shape up for us. But we expect success for us will look like a hardware-software integrated platform with multi-prone and multi-revenue streams. As Molecular Universe, a complete AI for Science workflow SaaS platform accelerates innovation across all battery chemistries, we are working with our JV partners to provide a dependable hardware supply chain for the cells developed from Molecular Universe. Just as AI for Science is completely changing other industries, Molecular Universe is now transforming all battery chemistries across all applications. We are excited about the revenue growth potential brought by Molecular Universe and will continue to assemble the best talent, data, and compute resource needed to build AI for Science for energy transition. Lastly, I want to express my gratitude for our teams who are working super hard to make all of this happen, and thanks to all of you for being on this journey with us. And now, here's Jin for financial updates.
Thank you. I will discuss our financial performance for the third quarter of 2025 and provide some context on how we are deploying our capital to support SES AI's long-term growth and then the all-in on AI strategy Chi-Chiu mentioned earlier. Revenue for the third quarter was $7.1 million, representing a $3.6 million, or 102% increase from the previous quarter. Our Q3 revenue was approximately a 55-45 split between our service revenue from our automotive OEM customers to develop AI-enhanced lithium metal and lithium-ion battery materials for EV applications and product revenue, primarily from UZ Energy's energy storage system sales. For the full year 2025, we're updating our revenue guidance to 20 million to 25 million due to UZ's contribution going forward. Growth margin was 51% for the third quarter, which is a combination of 78% growth margin from the service revenue and 15% growth margin from the product revenue. As a reminder, with Use the Energy Now part of SES, we expect growth margin variation from quarter to quarter as our service and product revenue mix will fluctuate. Our gap net loss for the third quarter was $20.9 million, or negative $0.06 per share. In Q2 2025, our gap net loss was $22.7 million, or negative $0.07 per share. As of September 30th, we had 365 million Class A and Class B shares outstanding, which were down $1.3 million from the previous quarter, mainly due to the share repurchase we executed during the third quarter. In the third quarter, we repurchased and canceled 1.3 million Class A shares for a total investment of 1.6 million, or roughly $1.20 per share. We utilized $14.3 million in cash flow operations in the third quarter. We exited the third quarter with a strongly graded position of $214 million. As mentioned, we closed the UZ acquisition in September and recognized some UCE revenue during the third quarter. We see a tremendous opportunity to grow the UCE energy business from approximately $10 million to $15 million in projected full-year 2025 revenue to a much larger growth in the coming years as we execute a go-to-market strategy that Qi Chao outlined to make market share gains in the $300 billion global ESS market. When we report Q4 earnings, we expect to provide a more definitive outlook on how we see the full-year 2026 revenue growth shaping up from this growth in ESS, best description use, contributions from Heisen JV, and potential for the start of commercial production of electrolytes and or battery cells from automotive OEMs, drones, and robotics. the potential growth of these revenue streams, which all have different margin profiles, will be much larger than what we have experienced in 2025. But the growth isn't linear from quarter to quarter, and the margin may vary quarter to quarter as well. Looking ahead, we remain focused on executing our strategy for continuing to grow our top line while remaining financially disciplined. With substantial liquidity, we are well-positioned for sustainable growth and long-term success. We appreciate your continued support and confidence in SESAI. Thank you. Now I will turn the call back to the operator.
In the question and answer session, if you'd like to ask a question, please press star followed by 1 on your telephone keypad now. If you change your mind, please press star followed by 2. When preparing to ask you a question, please ensure your device is unmuted locally. We will make a quick pause here for the questions to be registered. And our first question comes from the line of Derek Soderbergh with Contour Fitzgerald.
Yeah. Hey, thanks for taking the questions. On the Hi-Sun JV, can you talk about how that opportunity came about? Was the company paying for molecular universe access, or was this sort of an internal project at SES? And then what type of battery will this electrolyte enable?
Hey, Derek. Yeah, so very good question. And actually the Heisen JV can request by some of the Molecular Universe Enterprise users. So Molecular Universe, since we launched this earlier this year, has been growing really fast. And then we had almost every major battery company and battery materials company in the world trialing this. And so in addition to the SaaS platform, both on the cloud and also on-premise, several of the battery companies that are using the molecular universe enterprise tier also ask us, okay, we found these materials, these formulations, these molecules through molecular universe. Why don't you just make these and then sell these to us? Because they currently buy electrolytes from companies. So it's a quite mature business model. So we say, okay, yeah, we're happy to sell these materials to you. These are new formulations that they cannot buy anywhere else. And so we formed this joint venture. It's a CatPax JV. We control it. We control 90% of the JV. And then we contract manufacturer this company called HiZone to produce this formulation. And then we sell that formulation to the cell makers. And then some of the applications, so in Nepal, I listed three, and then actually all three are being produced. So the most popular one is a new formulation to improve low temperature performance of LFP for ESS batteries. A lot of these LFP batteries for ESS, when they're deployed in like Northern Europe, these cold places, they don't work so well when it's at low temperature. Another one is for cell phone applications. So it's a high voltage electrolyte for LCL cells. And then another is a 4% silicon lithium ion cells for EV applications, also to improve So these three, we are requested by the user, the cell maker, to actually supply these materials at commercial scale to them. And these were discovered through the Electric Universe platform.
Got it. That's helpful. And I guess just to that point, I guess I wasn't imagining, you know, a JV coming out of this first in Molecular Universe. Can you just talk about how you expect demonetization of that business to sort of play out over the next year? um you know beyond sort of jvs do you expect molecular universe to grow sort of as a traditional software as a service business where every quarter you sort of add additional seats or you know do you expect there to be sort of like a stair stepper um you know on stair step up on on revenue as you sign kind of larger agreements um how do you sort of see the monetization of mu playing out sort of the next year? How should we think about it?
Yeah. So MU is a mix of SaaS platform and materials. And then so the SaaS platform, and then we laid out the different tier pricing on the website, molecular-universe.com. And so we have the individual tiers and then the number of individual tiers is growing. And then also we have the enterprise tiers. These are the major battery companies and then the material companies and the chemical companies and then and a lot of these companies prefer on-premise so we also sell them this this molecular universe in a box on-premise solution so we charge them monthly subscription and also we we sell this this uh this computer that we actually deploy on site and also uh servers on top of them i think i think the sas platform we do expect to see a growing number of seeds per month and also per quarter and then the the material supply because a lot of these companies eventually want us to supply the materials but the revenue coming from the molecular universe discover materials is actually going to be much higher than the than the SAS revenue got it that's helpful and then just one final one for me just a broad update on molecular universe I think in the past you said you've got like two dozen or so companies in trial testing can you just give us an update on maybe where that is and you know I think in the past you have mentioned you know there are other
potential large or medium-sized battery OEMs as part of that group, where are you at with some of those players in negotiations? When do you expect maybe a medium or large-sized OEM to sign on to MU through a joint development? Thanks.
Yeah. Yeah. So, the number now is getting close to and then they've gone through MU25 trial, MU1.0 trial, which is the latest version, and they've gone through the initial cloud-based trial, and then now we are planning for on-premise deployment because a lot of these medium-sized, especially the larger-sized enterprises, they can do the cloud trial, but then eventually they will need this on-premise uh actual to actually deploy this this is why we're moving towards this uh this molecular universe uh in the box on-premise solution got it appreciate it thanks there thank you
so just as a reminder if you'd like to ask a question is there one on your telephone keypad the next question comes from winnie dong with deutsche bank hi thanks so much for taking my question um i just wanted to follow up with that last last question that was asked um you talked about you know launching three sub tiers within the enterprise subscription um i was wondering if you can maybe just elaborate on that what are they sort of looking for uh what are your customers looking for um and then if you can just maybe just uh remind us of the other um subscription options
um that's also bringing you this recurring revenue opportunity thank you yeah we so the um enterprise one two three basically they differ in terms of size of market database the depth of the models used and also the um the knowledge um and the know-how the models are are trained For example, Enterprise 1, we see that as like a PhD student level. And the Enterprise 2 is like a postdoc level. And the Enterprise 3 is a senior scientist level. And then, for example, Enterprise 1, when they answer a question, they'll answer a question typically less than three minutes. And the Enterprise 2 postdoc level answer a question in about five minutes. Enterprise 3 will answer a question in more than 30 minutes. the depth and the quality and the new discoveries are much deeper um so a lot of the enterprise ones are uh medium uh sized companies and also some startups and then the larger companies um and then so for enterprise one and two we offer only cloud and for enterprise three and even higher tiers joint development we offer a combination of cloud and also uh on-premise which most of the larger companies want and then in addition to these tiers we can also do the joint development tier with the larger customers that's where so um so so now the cloud version molecular universe is trained only on sds internal data but then for the joint development we will actually put our molecular universe in the box encrypted and then also uh organize the user's data the the the cell makers data and then have that train of like universe in a box and then we're helping them do something that they've always wanted to do but they've never had the resource and then never had the capability to do that got it that's that's very detailed thank you so much um and then so this quarter you saw some very um you know meaningful revenue contribution from from uzi
energy so i was just curious we can just maybe take a step back and um help us sort of get re-engaged with the background of this company where the markets are what you think you know the growth could be from this business and then maybe more broadly speaking as you look out to the different revenue streams so you know usually energy molecular universe you have the relationships with OEM Partners for Electrolyte Productions. Just maybe give us a sense of, you know, which channel you're most optimistic about as you head out to grow in the next, you know, two to three years.
Yeah, so UZ Energy is an energy storage company and they serve mainly the behind-the-meter commercial and industrial applications. And before we acquired UZ, We actually used to supply this database machine learning model to UZ to help improve the accuracy of their BMS, battery management system, in terms of predicting battery health and then end of life. And then since we acquired them, now we are adding more of these machine learning-based models, which is the predict feature in Molecular Universe MU 1.0. We are adding that into their BMS. So when we sell these, when UZ deploys these packs to customers around the world, a lot of the customers, for example, in Norway or Northern Europe, they complain that the packs, especially in winter, are just not so accurate and the BMS just stop working. So by adding this predict, we can actually, so each UZ pack is a box. is a molecular universe in a box and then and then we can gather data train the predict feature of my universe locally in the box and then make predictions about these issues before the customers can actually find out about the issues and then so since we've added this predict the amount of customer calls their complaints actually dropped and then we plan to continue to do that um so this application is actually really exciting so think of each ESS pack as a molecular universe in a box and then we collect the data we do local training and we make prediction on the safety and then I think that's a really exciting connection so we get data and we get revenue in terms of the overall growth of revenue of the different businesses opportunities that we mentioned usually this year revenue we expect to pull about 15 to 20 million and i think next year css we can at least double that um so this is one area another is drones drones this year we're getting our initial uh contracts and also a lot of the drones customers in the u.s really want uh cells uh made outside of china so we are making these cells in our changing south korea facility actually the amount of capacity for pouch cells for drones outside of china is like super rare it's hard to find pouch cells capacity outside of china we have them so we expect drones to also grow in a big way for us next year. And then EV, and so, for example, the joint development we had with Hyundai Motors and also Honda, we are using Life Universe to discover these new electrolytes. And then once we identify these electrolytes, then our plan is to use the Heisman JV to contract manufacture this and then supply. So I think next year, revenue-wise, total we should be able to at least double if not triple what we did this year because of all these opportunities that that are enabled by this molecular universe platform that's very helpful thank you just as another reminder it's part one on your telephone keypad to ask you question and as we have no further audio questions i will hand back over to kyle for the other
questions thank you as in past quarters we have received some written questions from investors and time permitting we'll go through a selection of those questions which have not yet been addressed on the call so the first question that we have relates to liquidity and whether management has a view on where liquidity is expected to be at the end of 2025 and will kind of scaling up of molecular universe or the UZ energy integration impact the cash burn or CapEx plans?
I can cover that. So our, yeah, yeah, I'll take that. So our liquidity balance is very strong. And given that we closed the UZ acquisition, also we did some stock repurchase based on our program, we still expect to exit the year with somewhere between $195 million to $200 million of liquidity. And then the other thing I wanted to probably emphasize is we're later focused on funding growth. So our liquidity balance is sufficient to kind of grow our revenue from different streams that Chi-Chiu just mentioned, whether it is ESS, drones, or materials, or assets from MAU. So the cash balance is no longer to fund runway. We have a CapEx Lite business model. So the UC acquisition is helping us to grow revenue with positive gross margin. All of our revenue sources come in on day one with a positive growth margin. So it's not a capex heavy business. So our liquidity balance will be sufficient to fund the growth going forward.
Great. The next question relates to molecular universe. And it goes, MU 1.0 is impressive.
Can you share the roadmap for MU for 2026 and what other features have been requested yeah so for now mu 1.0 has been mainly focused on electrolyte materials and then we've been requested to expand that to cover electrode process optimization and also cell design and manufacturing optimization and then another big request from some of the major battery companies they want their own molecular universe which is quite exciting because a lot of these battery companies they want to expand they want to build factories overseas in different continents and they need a a a battery bible so to speak basically put all their know-hows training this model into a portable molecular universe so that is going to be a really exciting project that we're going to be working on with these battery companies.
Excellent. And I think we have time for one more. So the last question is, if you could provide an update on the status on 2170 and LMA pouch cells for robotics, drones, and UAM, are you seeing good prospects for sales or do you see a need for scale up before promoting these more heavily?
Yeah. So the pouch cells, especially for drones, we're seeing a very interesting convergence and standardization of the format in the drones industry around this 10 amp hour pop cells and then so that's quite exciting and then we are converting our chungju line which we built both the ev line as well as the uam line we're converting that capacity to make this this pop cell and then so so far the capacity that we have uh missed the needs but So we're also seeing fast-growing demands, especially since it's produced in Korea. So we do see a quite exciting growth in this market.
Great. With that, I'll pass it back to the operator for closing remarks.
Thank you, everyone. This concludes today's call. Thank you for joining me, and I'll disconnect. Have a great rest of your day.
SEC filing · Item 2.02
Filed Nov 5, 2025 · complete as-filed document
SEC periodic report
Filed Nov 12, 2025 · complete as-filed document